PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 260 filers reported holding PACIRA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $971 | +15.5% | 31,641 | +50.8% | 0.08% | +4.2% |
| Q2 2023 | $841 | +10.2% | 20,977 | +12.2% | 0.07% | 0.0% |
| Q1 2023 | $763 | +37.5% | 18,694 | +30.0% | 0.07% | +12.5% |
| Q4 2022 | $555 | -99.9% | 14,381 | +6.3% | 0.06% | -28.1% |
| Q3 2022 | $720,000 | -3.7% | 13,529 | +5.5% | 0.09% | 0.0% |
| Q2 2022 | $748,000 | -23.0% | 12,827 | +0.7% | 0.09% | -13.6% |
| Q1 2022 | $972,000 | +28.6% | 12,742 | +1.4% | 0.10% | +24.1% |
| Q4 2021 | $756,000 | +99.5% | 12,564 | +85.7% | 0.08% | +48.2% |
| Q3 2021 | $379,000 | – | 6,766 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 550,000 | $18,442,000 | 6.98% |
| Gagnon Advisors, LLC | 193,860 | $6,500,000 | 6.06% |
| GAGNON SECURITIES LLC | 407,159 | $13,652,000 | 4.64% |
| Spyglass Capital Management LLC | 1,190,537 | $39,919,000 | 4.51% |
| Paulson & Co. | 1,716,727 | $57,562,000 | 2.20% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,627,521 | $54,571,000 | 1.73% |
| Elk Creek Partners, LLC | 265,146 | $8,890,000 | 1.53% |
| HealthCor Management, L.P. | 887,370 | $29,754,000 | 1.27% |
| Rock Springs Capital Management LP | 900,000 | $30,177,000 | 1.25% |
| Lisanti Capital Growth, LLC | 108,679 | $3,644,000 | 1.20% |